Clinical trial
Inflammatory Markers in Exhaled Breath (Condensate) in Childhood Asthma
NCT00404976 · Maastricht University Medical Center, Other · Completed
Key facts
| NCT number | NCT00404976 |
|---|---|
| Title | Inflammatory Markers in Exhaled Breath (Condensate) in Childhood Asthma |
| Official title | Biomarkers in Exhaled Breath (Condensate) Indicate Presence, Severity and Control of Asthma |
| Lead sponsor | Maastricht University Medical Center, Other |
| Collaborators | AstraZeneca Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Asthma, Healthy, Children |
| Enrollment | 100 |
| Start date | Jun 1, 2004 |
| Completion | Apr 1, 2005 |
| First posted | Nov 29, 2006 |
| Last update posted | Nov 29, 2006 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: